Paradigm Spine received FDA pre-market approval for its coflex Interlaminar Stabilization disposable instrument kit.
Here are four things to know.
1. As Paradigm Spine's flagship product, coflex Interlaminar Stabilization is a posterior lumbar motion preservation for patients with moderate to severe spinal stenosis.
2. In the U.S., lumbar spinal stenosis affects 1.6 million patients annually.
3. The newly approved coflex disposable instrument kit will consist of a complete and simplified injection molded instruments set delivered in a pre-sterilized peel pack.
4. This is the first disposable spinal instrument set for a Class III spinal device to receive a supplemental PMA approval, which is the most stringent type of device marketing application required by the FDA.
More articles on devices and implants:
K2M's Q1 2018 revenue spikes to $67.9M, complex spine segment experiences 8% growth
Stryker, Zimmer Biomet, Medtronic & more: 11 device company notes
Zimmer Biomet presents new technology platform for spine business: 4 observations